Randomized, Double-blind, Multicenter Study to Evaluate the Efficacy and Safety of MK-8808 versus MabThera in Patients with Advanced CD20-Positive Follicular Lymphoma.
Latest Information Update: 16 Jul 2013
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Doxorubicin; Prednisolone; Prednisone; Vincristine
- Indications Follicular lymphoma
- Focus Adverse reactions; Registrational; Therapeutic Use
- Acronyms SAME
- Sponsors Merck Sharp & Dohme
- 16 Jul 2013 New trial record